Cancer Treatment News and Research

RSS

Researchers discover a protein linked with the onset of anthracycline-associated cardiac toxicity

Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer.

27 Dec 2022

Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising results

A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers.

22 Dec 2022

Impact of epigenetics on the clinical management of cancer patients

Dr. Manel Esteller and Dr. Verónica Dávalos, researchers at the Josep Carreras Leukaemia Research Institute, describe in a new article the impact of epigenetics on cancer treatment and how it has become a crucial tool to improve early detection, predict disease progression and become a target for new treatments.

22 Dec 2022

CARxALL clinical trial approved to evaluate CAR-T technology for patients with T-cell leukemia subtype

The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial led by the company OneChain Immunotherapeutics (OCI).

21 Dec 2022

New method uses artificial DNA to target and kill cancer cells

Researchers at the University of Tokyo have used artificial DNA to target and kill cancer cells in a completely new way.

21 Dec 2022

Using 3D patient tumor avatars to guide cancer treatment decisions

At any time, most cancer patients are receiving a treatment that does not significantly benefit them while enduring bodily and financial toxicity.

20 Dec 2022

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

Pancreatic cancer is one of the deadliest types of cancer - in the U.S., it is estimated that over 88 percent of people will die from the disease within five years of their diagnosis.

20 Dec 2022

Researchers devise new biomarker-based strategy to screen for myocarditis caused by cancer treatment

Researchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by monoclonal antibodies used to treat several cancers.

20 Dec 2022

Scientists suggest vibrational spectroscopy and nuclear magnetic resonance to evaluate drug concentrations

Scientists at Baltic Federal University have suggested evaluating concentration and chemical composition of drugs by means of vibrational spectroscopy and nuclear magnetic resonance instead of conventional complex approaches.

20 Dec 2022

Understanding why young cancer survivors often opt out of HPV vaccination

Study uncovers certain vaccine-related concerns that should be addressed by health care providers.

19 Dec 2022

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway.

19 Dec 2022

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

In this interview, we speak to Steve Pointon, patient advocate in remission from RCC, and Dr Harm van Melick, Consultant Urologist, about their experiences with shared decision-making and the impact it can have on people living with renal cell carcinoma (RCC).

From Ipsen 15 Dec 2022

Study: Only 30% of people with neuroendocrine tumors consider living longer as top priority

New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that only 30% of patients with advanced neuroendocrine tumors (NETs) say their top goal for treatment is living longer.

12 Dec 2022

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology Annual Meeting.

12 Dec 2022

A-HIPI decision model can predict survival in adults with advanced-stage Hodgkin lymphoma

Investigators from Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center and leading cancer program along with Tufts Medical Center in Boston, developed and validated the Advanced-stage Hodgkin lymphoma International Prognostication Index (A-HIPI).

12 Dec 2022

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

Researchers investigates the impact of the COVID-19 pandemic on pancreatic cancer services in England.

11 Dec 2022

Better understanding of DNA repair mechanism may pave the way for effective cancer treatments

Better understanding of the mechanisms involved in DNA repair may pave the way for developing inhibitors to improve the effectiveness of radiation therapy.

9 Dec 2022

Georgia State brain researcher receives NIH grant to create a model for personalized cancer treatments

A brain researcher at Georgia State University has been awarded a five-year, $3.06 million grant from the National Cancer Institute at the National Institutes of Health to create a model for personalized cancer treatments.

8 Dec 2022

Leapfrog names USC Norris Cancer Hospital a 2022 Top Teaching Hospital

The Leapfrog Group, a national hospital watchdog organization, has named USC Norris Cancer Hospital a 2022 Top Teaching Hospital.

6 Dec 2022

Sociodemographic and modifiable risk factors increase odds of cardiovascular disease in AYA cancer survivors

Adolescent and young adult (AYA) cancer survivors are at risk of experiencing treatment-related effects later in life, including damage to the heart. New research has identified various sociodemographic and modifiable risk factors associated with these patients' risk of developing cardiovascular disease (CVD).

6 Dec 2022

Cancer Treatment News and Research

Researchers discover a protein linked with the onset of anthracycline-associated cardiac toxicity

Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising results

Impact of epigenetics on the clinical management of cancer patients

CARxALL clinical trial approved to evaluate CAR-T technology for patients with T-cell leukemia subtype

New method uses artificial DNA to target and kill cancer cells

Using 3D patient tumor avatars to guide cancer treatment decisions

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

Researchers devise new biomarker-based strategy to screen for myocarditis caused by cancer treatment

Scientists suggest vibrational spectroscopy and nuclear magnetic resonance to evaluate drug concentrations

Understanding why young cancer survivors often opt out of HPV vaccination

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Study: Only 30% of people with neuroendocrine tumors consider living longer as top priority

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

A-HIPI decision model can predict survival in adults with advanced-stage Hodgkin lymphoma

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

Better understanding of DNA repair mechanism may pave the way for effective cancer treatments

Georgia State brain researcher receives NIH grant to create a model for personalized cancer treatments

Leapfrog names USC Norris Cancer Hospital a 2022 Top Teaching Hospital

Sociodemographic and modifiable risk factors increase odds of cardiovascular disease in AYA cancer survivors

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News